metricas
covid
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging.
The Journal, which publishes six regular issues per year, is committed to fostering research and advancing continuing education across all domains of Nuclear Medicine. Its main sections include Original Articles, Images of Interest, and Special Collaboration papers. Manuscripts may be submitted in either Spanish or English and are subject to a rigorous peer-review process prior to publication.

See more Open Access Option

Indexed in:

Medline

See more

Follow us:

Subscribe:

tienda
Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more
Impact factor 2024
1.0
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2024
0.9
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2024
0.216
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2024
0.216
View more metrics
Hide
Issue
portada-S2253808925X00057Vol. 44. Issue 5.
(September - October 2025)
Original articles
Novel heterogeneity method for predicting survival in non-metastatic triple-negative breast cancer
G.B. Babacan, M. Öner Tamam, S. Saraçoğlu, M.N. Acar Tayyar, M.C. Şahin, H. Özçevik, G. Kulduk, Ö.B. Ekinci, E. Çelik
Rev Esp Med Nucl Imagen Mol. 2025;44:500112
Predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: The role of baseline volumetric 18F-FDG PET/CT parameters and inflammatory markers
Gokmen Umut Erdem, Ozge Vural Topuz, Esranur Acar, Tanju Kapagan, Esma Yetim, Aykut Ozmen, Simay Gurocak, Gamze Usul, ... Nilufer Bulut
Rev Esp Med Nucl Imagen Mol. 2025;44:500113
Influence of fever on 18F-FDG PET/CT in vivo: Utilizing a quantitative parameter SUL
S. Huang, M.S. Fang, M. Zhao, F. Li
Rev Esp Med Nucl Imagen Mol. 2025;44:500127
18F-choline PET/CT in the study of primary hyperparathyroidism: Evaluation of the technique, visual and semi-quantitative analysis and correlation with other imaging techniques
E. Campaña Díaz, F. Gómez-Caminero López, J. Manuel Álvarez Pérez, C. Montes Fuentes, S. Rama Alonso, J. Ángel Badell Martínez, P. García-Talavera San Miguel
Rev Esp Med Nucl Imagen Mol. 2025;44:500129
Model to predict the risk of cardiac death based on clinical characteristics and Gated-SPECT parameters
Grethel Rodríguez Cabalé, Eduardo Rodríguez Cabalé, Virginia Pubul Núñez, Álvaro Ruibal Morell
Rev Esp Med Nucl Imagen Mol. 2025;44:500132
Natriuretic factors and inflammation biomarkers as predictors of survival in [177Lu]Lu-DOTA-TATE therapy of neuroendocrine tumors
A. Piñeiro Donis, L. Menéndez-Muros, J.L. Villa-Palacios, E. Triviño-Ibáñez, M.A. Muros-Fuentes
Rev Esp Med Nucl Imagen Mol. 2025;44:500138
Interesting images
Striking pattern on [18F]FDG PET/CT in anti-NMDA receptor encephalitis
D.A. López-Mora, L. Lozano Murgas, M. Hervas Pujol, A.A. Rodríguez Revuelto
Rev Esp Med Nucl Imagen Mol. 2025;44:500084
Incidental detection of thyroid carcinoma and parathyroid adenoma with 18F-Fluorocholine PET/CT
G. Cuesta Domingo, C. Rodríguez Rey, A. Ortega Candil, P. Nespral Torres, S. Ochagavía Cámara, M.N. Cabrera Martín
Rev Esp Med Nucl Imagen Mol. 2025;44:500136
[18F]FDG PET/CT in suspected primary CNS lymphoma: Systemic involvement assessment and biopsy guidance
P. Dauden-Onate, C.G. Wakfie-Corieh, R.M. Couto-Caro, M.L. Suarez-Solis, C. Benavente-Cuesta, M.N. Cabrera-Martín
Rev Esp Med Nucl Imagen Mol. 2025;44:500140
18F-FDG PET-CT in multifocal hydatidosis
G. Molina-Mendoza, M. Talavera Rubio, F. López-Bermejo García, J. Gatón Ramírez, V. Poblete García
Rev Esp Med Nucl Imagen Mol. 2025;44:500176
Erdheim Chester disease: Diagnosis and follow-up on PET/CT [18F]FDG
S. López Puche, J.G. Villanueva Curto, P. García-Talavera San Miguel, J.A. Badell Martínez, S. Rama Alonso, M.P. Tamayo Alonso
Rev Esp Med Nucl Imagen Mol. 2025;44:500179
Continuing education
Revolutionizing prostate cancer treatment: PSMA-targeted therapy in modern therapeutics
A. Ricaurte-Fajardo, V. Marulanda-Corzo, S. Ruder, D.R. Cardoza-Ochoa, C.E. Granados, D. Yadav, D. López-Delgado, M. Fatima, ... S. Huicochea Castellanos
Rev Esp Med Nucl Imagen Mol. 2025;44:500162
Special collaborations
National survey on nuclear imaging in infectious bone pathology: Results and diagnostic recommendations of the Musculoskeletal Pathology Working Group (MSP-WG)
E. Noriega-Álvarez, A. Moreno-Ballesteros, M. Velasco Nuño, J.M. Cordero García, J.J. Rosales Castillo, U.V. Schmülling, E. López Rodríguez, A. Rigabert Sánchez-Junco, B. Rodríguez Alfonso
Rev Esp Med Nucl Imagen Mol. 2025;44:500165